id | C00002327 |
---|---|
Name | Colcin / Condylon / Colchisol / Colsaloid / Colchineos / Colchicine |
CAS RN | 64-86-8 |
Standard InChI | InChI=1S/C22H25NO6/c1-12(24)23-16-8-6-13-10-19(27-3)21(28-4)22(29-5)20(13)14-7-9-18(26-2)17(25)11-15(14)16/h7,9-11,16H,6,8H2,1-5H3,(H,23,24)/t16-/m0/s1 |
Standard InChI (Main Layer) | InChI=1S/C22H25NO6/c1-12(24)23-16-8-6-13-10-19(27-3)21(28-4)22(29-5)20(13)14-7-9-18(26-2)17(25)11-15(14)16/h7,9-11,16H,6,8H2,1-5H3,(H,23,24) |
Phytochemical cluster | No. 4 |
---|---|
KCF-S cluster | No. 598 |
By standard InChI | CHEMBL107 |
---|---|
By standard InChI Main Layer | CHEMBL87 CHEMBL107 CHEMBL330320 |
By LinkDB | C07592 |
---|
By CAS RN | D003078 |
---|
class name | count |
---|---|
Liliopsida | 26 |
family name | count |
---|---|
Colchicaceae | 25 |
Liliaceae | 1 |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL107 CHEMBL330320 |
CHEMBL1614110
(1)
CHEMBL1741321
(2)
CHEMBL1909136 (2) CHEMBL2071965 (1) |
1 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | CHEMBL107 |
CHEMBL1613992
(1)
|
7 / 44 |
Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | Electrochemical transporter | CHEMBL107 |
CHEMBL2169429
(1)
|
1 / 0 |
O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | CHEMBL107 |
CHEMBL2169431
(1)
|
0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | CHEMBL330320 |
CHEMBL2114784
(1)
|
1 / 1 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | CHEMBL107 |
CHEMBL1909139
(2)
|
0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | CHEMBL107 |
CHEMBL1909131
(2)
|
0 / 3 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | CHEMBL107 |
CHEMBL1909190
(2)
|
2 / 2 |
P08246 | Neutrophil elastase | S1A | CHEMBL107 |
CHEMBL1909195
(2)
|
2 / 1 |
P33765 | Adenosine receptor A3 | Adenosine receptor | CHEMBL107 |
CHEMBL1909215
(2)
|
0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | CHEMBL107 |
CHEMBL1909201
(2)
|
0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | CHEMBL107 |
CHEMBL1909176
(2)
|
0 / 0 |
P04062 | Glucosylceramidase | Enzyme | CHEMBL107 |
CHEMBL1613818
(1)
|
6 / 4 |
P29466 | Caspase-1 | C14 | CHEMBL107 |
CHEMBL1614158
(1)
CHEMBL1909193
(2)
|
0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | CHEMBL107 |
CHEMBL1909198
(2)
|
0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | CHEMBL107 |
CHEMBL1909199
(2)
|
0 / 0 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | CHEMBL107 |
CHEMBL1794524
(2)
CHEMBL1794552
(2)
|
0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | CHEMBL107 |
CHEMBL1909197
(2)
|
2 / 2 |
O15245 | Solute carrier family 22 member 1 | Drug uniporter | CHEMBL107 |
CHEMBL993349
(1)
|
0 / 0 |
Q92793 | CREB-binding protein | Enzyme | CHEMBL107 |
CHEMBL1614040
(1)
CHEMBL1614026
(1)
|
1 / 1 |
P02545 | Prelamin-A/C | Unclassified protein | CHEMBL107 CHEMBL330320 |
CHEMBL1614310
(1)
CHEMBL1614544
(3)
|
11 / 10 |
P23415 | Glycine receptor subunit alpha-1 | GLR alpha | CHEMBL107 |
CHEMBL1629222
(1)
|
1 / 1 |
P16473 | Thyrotropin receptor | Glycohormone receptor | CHEMBL107 CHEMBL330320 |
CHEMBL1614281
(2)
CHEMBL1614361
(3)
|
3 / 2 |
P10828 | Thyroid hormone receptor beta | NR1A2 | CHEMBL107 |
CHEMBL1794399
(2)
|
3 / 1 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | CHEMBL107 |
CHEMBL1794371
(3)
CHEMBL1794471
(1)
|
0 / 0 |
P00918 | Carbonic anhydrase 2 | Lyase | CHEMBL107 |
CHEMBL1909123
(2)
|
1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | CHEMBL107 |
CHEMBL1909092
(2)
|
0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | CHEMBL107 |
CHEMBL1909169
(2)
|
1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | CHEMBL107 |
CHEMBL1909157
(2)
|
0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | CHEMBL107 |
CHEMBL1909156
(2)
|
0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | CHEMBL107 |
CHEMBL1909143
(2)
|
1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | CHEMBL107 |
CHEMBL1909174
(2)
|
0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | CHEMBL107 |
CHEMBL1909090
(2)
|
0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | CHEMBL107 |
CHEMBL1909093
(2)
|
0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | CHEMBL107 |
CHEMBL755826
(1)
CHEMBL755827
(1)
CHEMBL754160 (1) CHEMBL754161 (1) CHEMBL1908285 (1) CHEMBL1908286 (1) CHEMBL1908289 (1) CHEMBL1908291 (1) CHEMBL1908292 (1) CHEMBL2077417 (1) CHEMBL2076102 (1) CHEMBL2076103 (1) CHEMBL2076285 (1) CHEMBL2076286 (1) CHEMBL2077349 (1) CHEMBL2075838 (1) CHEMBL2076207 (1) CHEMBL2076208 (1) CHEMBL2076209 (1) CHEMBL2076217 (1) CHEMBL2076219 (1) |
1 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | CHEMBL107 |
CHEMBL1909127
(2)
|
0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | CHEMBL107 |
CHEMBL1909204
(2)
|
0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | CHEMBL107 |
CHEMBL1909202
(2)
|
0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL107 CHEMBL330320 |
CHEMBL1614027
(2)
CHEMBL1741325
(2)
CHEMBL1909135 (2) CHEMBL2071963 (1) |
0 / 1 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | CHEMBL107 |
CHEMBL1614166
(2)
|
1 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | CHEMBL107 |
CHEMBL1909203
(2)
|
1 / 11 |
P11473 | Vitamin D3 receptor | NR1I1 | CHEMBL107 |
CHEMBL1794376
(1)
|
2 / 3 |
P14416 | D(2) dopamine receptor | Dopamine receptor | CHEMBL107 |
CHEMBL1909140
(2)
|
2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | CHEMBL107 |
CHEMBL1909130
(2)
|
0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | CHEMBL107 |
CHEMBL1909120
(2)
|
0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | CHEMBL107 |
CHEMBL1909181
(2)
|
0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | CHEMBL107 |
CHEMBL1909164
(2)
|
0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | CHEMBL107 |
CHEMBL1909214
(2)
|
0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | CHEMBL107 |
CHEMBL1909175
(2)
|
0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | CHEMBL107 |
CHEMBL1909096
(2)
|
1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | CHEMBL107 |
CHEMBL1909118
(2)
|
0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | CHEMBL107 |
CHEMBL1909166
(2)
|
1 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | CHEMBL107 |
CHEMBL1909133
(2)
|
0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | CHEMBL330320 |
CHEMBL1614456
(1)
CHEMBL1613803
(1)
|
0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | CHEMBL107 |
CHEMBL1794486
(1)
|
0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | CHEMBL87 |
CHEMBL1738606
(1)
|
0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | CHEMBL107 |
CHEMBL1794584
(1)
|
2 / 0 |
O75496 | Geminin | Unclassified protein | CHEMBL87 CHEMBL107 |
CHEMBL1613941
(1)
CHEMBL1738370
(1)
CHEMBL1738636 (1) CHEMBL1737957 (1) CHEMBL2114843 (2) CHEMBL2114780 (3) |
0 / 0 |
P51151 | Ras-related protein Rab-9A | Unclassified protein | CHEMBL107 |
CHEMBL1613838
(2)
|
0 / 0 |
P23416 | Glycine receptor subunit alpha-2 | GLR alpha | CHEMBL107 |
CHEMBL1629262
(1)
|
0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | CHEMBL107 |
CHEMBL1909158
(2)
|
0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | CHEMBL107 |
CHEMBL1909088
(2)
|
0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | CHEMBL107 |
CHEMBL1909142
(2)
|
0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | CHEMBL107 |
CHEMBL1909101
(2)
|
0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | CHEMBL107 |
CHEMBL1909141
(2)
|
1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | CHEMBL107 |
CHEMBL1909180
(2)
|
0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | CHEMBL107 |
CHEMBL1909146
(2)
|
0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | CHEMBL107 |
CHEMBL1909104
(2)
|
0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | CHEMBL107 |
CHEMBL1909144
(2)
|
0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | CHEMBL107 |
CHEMBL1909100
(2)
|
0 / 0 |
P10145 | Interleukin-8 | Secreted protein | CHEMBL107 |
CHEMBL2114835
(2)
|
0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | CHEMBL107 |
CHEMBL1909167
(2)
|
1 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | CHEMBL107 |
CHEMBL1909129
(2)
|
0 / 0 |
P08311 | Cathepsin G | S1A | CHEMBL107 |
CHEMBL1909194
(2)
|
0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | CHEMBL107 |
CHEMBL1909110
(2)
|
1 / 0 |
P03956 | Interstitial collagenase | M10A | CHEMBL107 |
CHEMBL1909196
(2)
|
0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | CHEMBL107 |
CHEMBL1909119
(2)
|
0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | CHEMBL87 |
CHEMBL2114817
(1)
|
7 / 3 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | CHEMBL87 |
CHEMBL1614410
(1)
|
1 / 3 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | CHEMBL107 |
CHEMBL1738610
(1)
|
0 / 0 |
Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | Electrochemical transporter | CHEMBL107 |
CHEMBL2169430
(1)
|
1 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | CHEMBL107 |
CHEMBL1794467
(1)
|
0 / 0 |
P51843 | Nuclear receptor subfamily 0 group B member 1 | Nuclear hormone receptor subfamily 0 group B member 1 | CHEMBL107 |
CHEMBL2354292
(1)
|
2 / 2 |
P04150 | Glucocorticoid receptor | NR3C1 | CHEMBL107 |
CHEMBL1794382
(1)
CHEMBL1794456
(1)
CHEMBL1909150 (2) |
0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | CHEMBL107 |
CHEMBL1909171
(2)
|
2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | CHEMBL107 |
CHEMBL1909170
(2)
|
0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | CHEMBL107 |
CHEMBL1909122
(2)
|
0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | CHEMBL107 |
CHEMBL1909109
(2)
|
2 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | CHEMBL107 |
CHEMBL1794510
(3)
|
5 / 3 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | CHEMBL107 |
CHEMBL1909205
(2)
|
5 / 10 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | CHEMBL107 |
CHEMBL1909172
(2)
|
1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | CHEMBL107 |
CHEMBL1909114
(2)
|
0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | CHEMBL107 |
CHEMBL1909125
(2)
|
0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | CHEMBL107 |
CHEMBL1909126
(2)
|
3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | CHEMBL107 |
CHEMBL1909108
(2)
|
0 / 0 |
Q96RI1 | Bile acid receptor | NR1H4 | CHEMBL107 |
CHEMBL1794415
(2)
CHEMBL1794437
(1)
|
0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | CHEMBL107 |
CHEMBL1909124
(2)
|
1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL107 |
CHEMBL1909200
(2)
|
0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | CHEMBL107 |
CHEMBL1909207
(2)
|
2 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL107 CHEMBL330320 |
CHEMBL1741322
(2)
CHEMBL1909132
(2)
CHEMBL2071962 (1) |
0 / 0 |
Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | CHEMBL107 |
CHEMBL1006005
(1)
|
1 / 1 |
O75030 | Microphthalmia-associated transcription factor | Unclassified protein | CHEMBL87 |
CHEMBL1738671
(1)
CHEMBL1737866
(1)
CHEMBL1738318 (1) |
4 / 5 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | CHEMBL107 |
CHEMBL2114842
(2)
|
0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | CHEMBL87 CHEMBL107 |
CHEMBL1738588
(2)
CHEMBL1737868
(1)
|
0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | CHEMBL107 |
CHEMBL1909186
(2)
|
0 / 0 |
P03372 | Estrogen receptor | NR3A1 | CHEMBL107 |
CHEMBL1794542
(1)
CHEMBL1909145
(2)
|
1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | CHEMBL107 |
CHEMBL1909091
(2)
|
1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | CHEMBL107 |
CHEMBL1909212
(2)
|
1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | CHEMBL107 |
CHEMBL1909211
(2)
|
0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | CHEMBL107 |
CHEMBL1909105
(2)
|
0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | CHEMBL107 |
CHEMBL1909182
(2)
|
0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | CHEMBL107 |
CHEMBL1909173
(2)
|
0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | CHEMBL107 |
CHEMBL1909113
(2)
|
0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | CHEMBL107 |
CHEMBL1909187
(2)
|
0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | CHEMBL107 |
CHEMBL1909168
(2)
|
0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL107 CHEMBL330320 |
CHEMBL1613777
(1)
CHEMBL1741323
(2)
CHEMBL1909134 (2) CHEMBL2071964 (1) |
1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL107 CHEMBL330320 |
CHEMBL664809
(1)
CHEMBL836230
(1)
CHEMBL1614108 (1) CHEMBL1613886 (1) CHEMBL1741324 (2) CHEMBL1909138 (2) CHEMBL2071966 (1) CHEMBL2071967 (1) |
0 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | CHEMBL107 |
CHEMBL1909137
(2)
|
0 / 0 |
Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | CHEMBL107 |
CHEMBL1614052
(1)
|
1 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | CHEMBL87 CHEMBL107 |
CHEMBL1737980
(1)
CHEMBL1738184
(2)
CHEMBL2114890 (3) |
0 / 0 |
P10275 | Androgen receptor | NR3C4 | CHEMBL107 |
CHEMBL1794560
(2)
|
3 / 4 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | CHEMBL107 |
CHEMBL1909094
(2)
|
1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | CHEMBL107 |
CHEMBL1909087
(2)
|
0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | CHEMBL107 |
CHEMBL1909213
(2)
|
0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | CHEMBL107 |
CHEMBL1909089
(2)
|
0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | CHEMBL107 |
CHEMBL1909116
(2)
|
1 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | CHEMBL107 |
CHEMBL1909206
(2)
|
0 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | CHEMBL107 |
CHEMBL1909128
(2)
|
0 / 0 |
P40225 | Thrombopoietin | Unclassified protein | CHEMBL107 |
CHEMBL1614086
(1)
CHEMBL1614034
(1)
|
1 / 1 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | CHEMBL107 |
CHEMBL1738442
(1)
|
0 / 0 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | CHEMBL87 CHEMBL107 |
CHEMBL2354311
(2)
|
1 / 0 |
O75751 | Solute carrier family 22 member 3 | Unclassified protein | CHEMBL107 |
CHEMBL2075864
(1)
|
0 / 0 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | CHEMBL107 |
CHEMBL817421
(1)
CHEMBL847691
(1)
|
0 / 0 |
Q02880 | DNA topoisomerase 2-beta | Isomerase | CHEMBL107 |
CHEMBL817421
(1)
CHEMBL847691
(1)
|
0 / 0 |
Q13748 | Tubulin alpha-3C/D chain | Structural | CHEMBL107 CHEMBL330320 |
CHEMBL698214
(1)
CHEMBL818984
(1)
CHEMBL820637 (2) CHEMBL820638 (1) CHEMBL819249 (1) CHEMBL819251 (1) CHEMBL816885 (1) CHEMBL817774 (1) CHEMBL817775 (1) CHEMBL845253 (1) CHEMBL861004 (1) CHEMBL870821 (1) CHEMBL910862 (1) CHEMBL907127 (1) CHEMBL912968 (1) |
0 / 0 |
P68366 | Tubulin alpha-4A chain | Structural | CHEMBL107 CHEMBL330320 |
CHEMBL698214
(1)
CHEMBL818984
(1)
CHEMBL820637 (2) CHEMBL820638 (1) CHEMBL819249 (1) CHEMBL819251 (1) CHEMBL816885 (1) CHEMBL817774 (1) CHEMBL817775 (1) CHEMBL845253 (1) CHEMBL861004 (1) CHEMBL870821 (1) CHEMBL910862 (1) CHEMBL907127 (1) CHEMBL912968 (1) |
0 / 0 |
Q9H4B7 | Tubulin beta-1 chain | Structural | CHEMBL107 CHEMBL330320 |
CHEMBL698214
(1)
CHEMBL818984
(1)
CHEMBL820637 (2) CHEMBL820638 (1) CHEMBL819249 (1) CHEMBL819251 (1) CHEMBL816885 (1) CHEMBL817774 (1) CHEMBL817775 (1) CHEMBL845253 (1) CHEMBL861004 (1) CHEMBL870821 (1) CHEMBL910862 (1) CHEMBL907127 (1) CHEMBL912968 (1) |
1 / 0 |
P04350 | Tubulin beta-4A chain | Structural | CHEMBL107 CHEMBL330320 |
CHEMBL698214
(1)
CHEMBL818984
(1)
CHEMBL820637 (2) CHEMBL820638 (1) CHEMBL819249 (1) CHEMBL819251 (1) CHEMBL816885 (1) CHEMBL817774 (1) CHEMBL817775 (1) CHEMBL845253 (1) CHEMBL861004 (1) CHEMBL870821 (1) CHEMBL910862 (1) CHEMBL907127 (1) CHEMBL912968 (1) |
2 / 0 |
Q3ZCM7 | Tubulin beta-8 chain | Structural | CHEMBL107 CHEMBL330320 |
CHEMBL698214
(1)
CHEMBL818984
(1)
CHEMBL820637 (2) CHEMBL820638 (1) CHEMBL819249 (1) CHEMBL819251 (1) CHEMBL816885 (1) CHEMBL817774 (1) CHEMBL817775 (1) CHEMBL845253 (1) CHEMBL861004 (1) CHEMBL870821 (1) CHEMBL910862 (1) CHEMBL907127 (1) CHEMBL912968 (1) |
0 / 0 |
P07437 | Tubulin beta chain | Structural | CHEMBL107 CHEMBL330320 |
CHEMBL698214
(1)
CHEMBL818984
(1)
CHEMBL820637 (2) CHEMBL820638 (1) CHEMBL819249 (1) CHEMBL819251 (1) CHEMBL816885 (1) CHEMBL817774 (1) CHEMBL817775 (1) CHEMBL845253 (1) CHEMBL861004 (1) CHEMBL870821 (1) CHEMBL910862 (1) CHEMBL907127 (1) CHEMBL912968 (1) |
0 / 0 |
Q71U36 | Tubulin alpha-1A chain | Structural | CHEMBL107 CHEMBL330320 |
CHEMBL698214
(1)
CHEMBL818984
(1)
CHEMBL820637 (2) CHEMBL820638 (1) CHEMBL819249 (1) CHEMBL819251 (1) CHEMBL816885 (1) CHEMBL817774 (1) CHEMBL817775 (1) CHEMBL845253 (1) CHEMBL861004 (1) CHEMBL870821 (1) CHEMBL910862 (1) CHEMBL907127 (1) CHEMBL912968 (1) |
1 / 1 |
P68371 | Tubulin beta-4B chain | Structural | CHEMBL107 CHEMBL330320 |
CHEMBL698214
(1)
CHEMBL818984
(1)
CHEMBL820637 (2) CHEMBL820638 (1) CHEMBL819249 (1) CHEMBL819251 (1) CHEMBL816885 (1) CHEMBL817774 (1) CHEMBL817775 (1) CHEMBL845253 (1) CHEMBL861004 (1) CHEMBL870821 (1) CHEMBL910862 (1) CHEMBL907127 (1) CHEMBL912968 (1) |
0 / 0 |
Q13509 | Tubulin beta-3 chain | Structural | CHEMBL107 CHEMBL330320 |
CHEMBL698214
(1)
CHEMBL818984
(1)
CHEMBL820637 (2) CHEMBL820638 (1) CHEMBL819249 (1) CHEMBL819251 (1) CHEMBL816885 (1) CHEMBL817774 (1) CHEMBL817775 (1) CHEMBL845253 (1) CHEMBL861004 (1) CHEMBL870821 (1) CHEMBL910862 (1) CHEMBL907127 (1) CHEMBL912968 (1) |
2 / 1 |
Q06710 | Paired box protein Pax-8 | Unclassified protein | CHEMBL87 CHEMBL107 |
CHEMBL2354301
(2)
|
1 / 2 |
P68363 | Tubulin alpha-1B chain | Unclassified protein | CHEMBL107 CHEMBL330320 |
CHEMBL698214
(1)
CHEMBL818984
(1)
CHEMBL820637 (2) CHEMBL820638 (1) CHEMBL819249 (1) CHEMBL819251 (1) CHEMBL816885 (1) CHEMBL817774 (1) CHEMBL817775 (1) CHEMBL845253 (1) CHEMBL861004 (1) CHEMBL870821 (1) CHEMBL910862 (1) CHEMBL907127 (1) CHEMBL912968 (1) |
0 / 0 |
Q13885 | Tubulin beta-2A chain | Structural | CHEMBL107 CHEMBL330320 |
CHEMBL698214
(1)
CHEMBL818984
(1)
CHEMBL820637 (2) CHEMBL820638 (1) CHEMBL819249 (1) CHEMBL819251 (1) CHEMBL816885 (1) CHEMBL817774 (1) CHEMBL817775 (1) CHEMBL845253 (1) CHEMBL861004 (1) CHEMBL870821 (1) CHEMBL910862 (1) CHEMBL907127 (1) CHEMBL912968 (1) |
0 / 0 |
Q6PEY2 | Tubulin alpha-3E chain | Unclassified protein | CHEMBL107 CHEMBL330320 |
CHEMBL698214
(1)
CHEMBL818984
(1)
CHEMBL820637 (2) CHEMBL820638 (1) CHEMBL819249 (1) CHEMBL819251 (1) CHEMBL816885 (1) CHEMBL817774 (1) CHEMBL817775 (1) CHEMBL845253 (1) CHEMBL861004 (1) CHEMBL870821 (1) CHEMBL910862 (1) CHEMBL907127 (1) CHEMBL912968 (1) |
0 / 0 |
Q9BQE3 | Tubulin alpha-1C chain | Unclassified protein | CHEMBL107 CHEMBL330320 |
CHEMBL698214
(1)
CHEMBL818984
(1)
CHEMBL820637 (2) CHEMBL820638 (1) CHEMBL819249 (1) CHEMBL819251 (1) CHEMBL816885 (1) CHEMBL817774 (1) CHEMBL817775 (1) CHEMBL845253 (1) CHEMBL861004 (1) CHEMBL870821 (1) CHEMBL910862 (1) CHEMBL907127 (1) CHEMBL912968 (1) |
0 / 0 |
Q9BUF5 | Tubulin beta-6 chain | Structural | CHEMBL107 CHEMBL330320 |
CHEMBL698214
(1)
CHEMBL818984
(1)
CHEMBL820637 (2) CHEMBL820638 (1) CHEMBL819249 (1) CHEMBL819251 (1) CHEMBL816885 (1) CHEMBL817774 (1) CHEMBL817775 (1) CHEMBL845253 (1) CHEMBL861004 (1) CHEMBL870821 (1) CHEMBL910862 (1) CHEMBL907127 (1) CHEMBL912968 (1) |
0 / 0 |
Q9BVA1 | Tubulin beta-2B chain | Structural | CHEMBL107 CHEMBL330320 |
CHEMBL698214
(1)
CHEMBL818984
(1)
CHEMBL820637 (2) CHEMBL820638 (1) CHEMBL819249 (1) CHEMBL819251 (1) CHEMBL816885 (1) CHEMBL817774 (1) CHEMBL817775 (1) CHEMBL845253 (1) CHEMBL861004 (1) CHEMBL870821 (1) CHEMBL910862 (1) CHEMBL907127 (1) CHEMBL912968 (1) |
1 / 0 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
D003078 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | ABCB1 protein affects the transport of Colchicine |
affects transport
|
protein |
16007523
|
D003078 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | ABCB1 protein results in decreased susceptibility to Colchicine |
decreases response to substance
|
protein |
7905786
15112361 15725475 |
D003078 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | ABCB1 protein results in increased export of Colchicine |
increases export
|
protein |
15112361
|
D003078 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | Colchicine inhibits the reaction [Verapamil analog results in increased activity of ABCB1 protein mutant form] |
decreases reaction
/ increases activity |
protein |
12711602
|
D003078 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | Colchicine results in increased expression of ABCB1 mRNA |
increases expression
|
mRNA |
15342794
|
D003078 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | [MGMT protein co-treated with ABCB1 protein] results in decreased susceptibility to Colchicine |
affects cotreatment
/ decreases response to substance |
protein |
11792417
|
D003078 | 4363 |
ABCC1
ABC29 ABCC GS-X MRP MRP1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | ABCC1 protein results in decreased susceptibility to Colchicine |
decreases response to substance
|
protein |
12067707
|
D003078 | 196 |
AHR
bHLHe76 |
aryl hydrocarbon receptor | Colchicine results in decreased activity of AHR protein |
decreases activity
|
protein |
16611024
|
D003078 | 213 |
ALB
PRO0883 PRO0903 PRO1341 |
albumin | Colchicine affects the expression of ALB protein |
affects expression
|
protein |
8574231
|
D003078 | 9212 |
AURKB
AIK2 AIM-1 AIM1 ARK2 AurB IPL1 PPP1R48 STK12 STK5 aurkb-sv1 aurkb-sv2 |
aurora kinase B (EC:2.7.11.1) | Colchicine results in increased expression of AURKB mRNA |
increases expression
|
mRNA |
21472861
|
D003078 | 581 |
BAX
BCL2L4 |
BCL2-associated X protein | Colchicine results in increased expression of BAX protein |
increases expression
|
protein |
22342440
|
D003078 | 596 |
BCL2
Bcl-2 PPP1R50 |
B-cell CLL/lymphoma 2 | Colchicine results in decreased expression of BCL2 protein |
decreases expression
|
protein |
22342440
|
D003078 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | Colchicine results in increased activity of CASP3 protein |
increases activity
|
protein |
22342440
|
D003078 | 842 |
CASP9
APAF-3 APAF3 ICE-LAP6 MCH6 PPP1R56 |
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) | Colchicine results in increased activity of CASP9 protein |
increases activity
|
protein |
22342440
|
D003078 | 891 |
CCNB1
CCNB |
cyclin B1 | Colchicine results in increased expression of CCNB1 mRNA |
increases expression
|
mRNA |
21472861
|
D003078 | 966 |
CD59
16.3A5 1F5 EJ16 EJ30 EL32 G344 HRF-20 HRF20 MAC-IP MACIF MEM43 MIC11 MIN1 MIN2 MIN3 MIRL MSK21 p18-20 |
CD59 molecule, complement regulatory protein | Colchicine results in increased mutagenesis of CD59 protein |
increases mutagenesis
|
protein |
17045307
|
D003078 | 999 |
CDH1
Arc-1 CD324 CDHE ECAD LCAM UVO |
cadherin 1, type 1, E-cadherin (epithelial) | Colchicine affects the activity of CDH1 protein |
affects activity
|
protein |
10413674
|
D003078 | 10659 |
CELF2
BRUNOL3 CUGBP2 ETR-3 ETR3 NAPOR |
CUGBP, Elav-like family member 2 | 2-cyclopentyl-5-(5-isoquinolylsulfonyl)-6-nitro-1H-benzo(D)imidazole inhibits the reaction [Colchicine results in increased expression of CELF2 mRNA] |
decreases reaction
/ increases expression |
mRNA |
11478917
|
D003078 | 10659 |
CELF2
BRUNOL3 CUGBP2 ETR-3 ETR3 NAPOR |
CUGBP, Elav-like family member 2 | Colchicine results in increased expression of CELF2 mRNA |
increases expression
|
mRNA |
11478917
|
D003078 | 1437 |
CSF2
GMCSF |
colony stimulating factor 2 (granulocyte-macrophage) | Colchicine inhibits the reaction [kaempferol results in increased secretion of CSF2 protein] |
decreases reaction
/ increases secretion |
protein |
18346843
|
D003078 | 1437 |
CSF2
GMCSF |
colony stimulating factor 2 (granulocyte-macrophage) | Colchicine inhibits the reaction [Quercetin results in increased secretion of CSF2 protein] |
decreases reaction
/ increases secretion |
protein |
18346843
|
D003078 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Colchicine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] |
decreases reaction
/ increases activity |
protein |
16611024
|
D003078 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Colchicine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
16611024
|
D003078 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Colchicine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein] |
decreases reaction
/ increases expression |
protein |
16611024
|
D003078 | 1576 |
CYP3A4
CP33 CP34 CYP3A CYP3A3 CYPIIIA3 CYPIIIA4 HLP NF-25 P450C3 P450PCN1 |
cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) | CYP3A4 protein affects the metabolism of Colchicine |
affects metabolic processing
|
protein |
15914514
16007523 |
D003078 | 2147 |
F2
PT RPRGL2 THPH1 |
coagulation factor II (thrombin) (EC:3.4.21.5) | Colchicine affects the activity of F2 protein |
affects activity
|
protein |
8574231
|
D003078 | 3551 |
IKBKB
IKK-beta IKK2 IKKB NFKBIKB |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10) | Colchicine results in decreased localization of [IKBKB protein binds to NFKBIA protein] |
affects binding
/ decreases localization |
protein |
17029595
|
D003078 | 3551 |
IKBKB
IKK-beta IKK2 IKKB NFKBIKB |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10) | Colchicine results in increased phosphorylation of IKBKB protein |
increases phosphorylation
|
protein |
17029595
|
D003078 | 3552 |
IL1A
IL-1A IL1 IL1-ALPHA IL1F1 |
interleukin 1, alpha | Colchicine inhibits the reaction [IL1A protein results in increased expression of VCAM1 protein] |
decreases reaction
/ increases expression |
protein |
11154858
|
D003078 | 3558 |
IL2
IL-2 TCGF lymphokine |
interleukin 2 | Colchicine results in decreased expression of IL2 protein |
decreases expression
|
protein |
1553933
|
D003078 | 3725 |
JUN
AP-1 AP1 c-Jun |
jun proto-oncogene | Colchicine results in increased phosphorylation of JUN protein |
increases phosphorylation
|
protein |
12221076
|
D003078 | 3725 |
JUN
AP-1 AP1 c-Jun |
jun proto-oncogene | TP53 protein affects the reaction [Colchicine results in increased phosphorylation of JUN protein] |
affects reaction
/ increases phosphorylation |
protein |
12221076
|
D003078 | 3875 |
KRT18
CYK18 K18 |
keratin 18 | Colchicine results in decreased expression of KRT18 protein |
decreases expression
|
protein |
11259854
|
D003078 | 5599 |
MAPK8
JNK JNK-46 JNK1 JNK1A2 JNK21B1/2 PRKM8 SAPK1 SAPK1c |
mitogen-activated protein kinase 8 (EC:2.7.11.24) | Colchicine results in increased phosphorylation of MAPK8 protein |
increases phosphorylation
|
protein |
12221076
|
D003078 | 5599 |
MAPK8
JNK JNK-46 JNK1 JNK1A2 JNK21B1/2 PRKM8 SAPK1 SAPK1c |
mitogen-activated protein kinase 8 (EC:2.7.11.24) | TP53 protein affects the reaction [Colchicine results in increased phosphorylation of MAPK8 protein] |
affects reaction
/ increases phosphorylation |
protein |
12221076
|
D003078 | 5601 |
MAPK9
JNK-55 JNK2 JNK2A JNK2ALPHA JNK2B JNK2BETA PRKM9 SAPK SAPK1a p54a p54aSAPK |
mitogen-activated protein kinase 9 (EC:2.7.11.24) | Colchicine results in increased phosphorylation of MAPK9 protein |
increases phosphorylation
|
protein |
12221076
|
D003078 | 5601 |
MAPK9
JNK-55 JNK2 JNK2A JNK2ALPHA JNK2B JNK2BETA PRKM9 SAPK SAPK1a p54a p54aSAPK |
mitogen-activated protein kinase 9 (EC:2.7.11.24) | TP53 protein affects the reaction [Colchicine results in increased phosphorylation of MAPK9 protein] |
affects reaction
/ increases phosphorylation |
protein |
12221076
|
D003078 | 4137 |
MAPT
DDPAC FTDP-17 MAPTL MSTD MTBT1 MTBT2 PPND TAU |
microtubule-associated protein tau | Colchicine results in decreased expression of MAPT protein |
decreases expression
|
protein |
16930453
|
D003078 | 4255 |
MGMT
|
O-6-methylguanine-DNA methyltransferase (EC:2.1.1.63) | [MGMT protein co-treated with ABCB1 protein] results in decreased susceptibility to Colchicine |
affects cotreatment
/ decreases response to substance |
protein |
11792417
|
D003078 | 4661 |
MYT1
C20orf36 MTF1 MYTI PLPB1 ZC2HC4A |
myelin transcription factor 1 | Colchicine results in increased phosphorylation of MYT1 protein |
increases phosphorylation
|
protein |
16611024
|
D003078 | 4776 |
NFATC4
NF-ATc4 NFAT3 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 | Colchicine results in decreased localization of NFATC4 protein |
decreases localization
|
protein |
17044076
|
D003078 | 4792 |
NFKBIA
IKBA MAD-3 NFKBI |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | Colchicine results in decreased localization of [IKBKB protein binds to NFKBIA protein] |
affects binding
/ decreases localization |
protein |
17029595
|
D003078 | 4792 |
NFKBIA
IKBA MAD-3 NFKBI |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | Colchicine results in increased phosphorylation of NFKBIA protein |
increases phosphorylation
|
protein |
17029595
|
D003078 | 2908 |
NR3C1
GCCR GCR GR GRL |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | Colchicine results in decreased localization of and results in decreased activity of NR3C1 protein |
decreases activity
/ decreases localization |
protein |
15744361
|
D003078 | 2908 |
NR3C1
GCCR GCR GR GRL |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | Colchicine results in increased activity of NR3C1 protein |
increases activity
|
protein |
20448266
|
D003078 | 2908 |
NR3C1
GCCR GCR GR GRL |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | Colchicine results in increased degradation of NR3C1 protein |
increases degradation
|
protein |
20448266
|
D003078 | 2185 |
PTK2B
CADTK CAKB FADK2 FAK2 PKB PTK PYK2 RAFTK |
protein tyrosine kinase 2 beta (EC:2.7.10.2) | 2-cyclopentyl-5-(5-isoquinolylsulfonyl)-6-nitro-1H-benzo(D)imidazole inhibits the reaction [Colchicine results in increased phosphorylation of PTK2B protein] |
decreases reaction
/ increases phosphorylation |
protein |
11478917
|
D003078 | 2185 |
PTK2B
CADTK CAKB FADK2 FAK2 PKB PTK PYK2 RAFTK |
protein tyrosine kinase 2 beta (EC:2.7.10.2) | Colchicine results in increased phosphorylation of PTK2B protein |
increases phosphorylation
|
protein |
11478917
|
D003078 | 10928 |
RALBP1
RIP1 RLIP1 RLIP76 |
ralA binding protein 1 | Colchicine inhibits the reaction [RALBP1 protein affects the transport of Leukotriene C4] |
affects transport
/ decreases reaction |
protein |
15386349
|
D003078 | 10928 |
RALBP1
RIP1 RLIP1 RLIP76 |
ralA binding protein 1 | RALBP1 protein affects the transport of Colchicine |
affects transport
|
protein |
15386349
|
D003078 | 6898 |
TAT
|
tyrosine aminotransferase (EC:2.6.1.5) | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Colchicine results in decreased expression of TAT mRNA] |
decreases expression
/ decreases reaction |
mRNA |
15744361
|
D003078 | 6898 |
TAT
|
tyrosine aminotransferase (EC:2.6.1.5) | Colchicine results in decreased expression of TAT mRNA |
decreases expression
|
mRNA |
15744361
|
D003078 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Colchicine inhibits the reaction [TNF protein results in increased expression of VCAM1 protein] |
decreases reaction
/ increases expression |
protein |
11154858
|
D003078 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Colchicine results in decreased expression of TNF protein |
decreases expression
|
protein |
1553933
|
D003078 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Paclitaxel inhibits the reaction [Colchicine inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]] |
decreases reaction
/ increases expression |
protein |
11154858
|
D003078 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Paclitaxel inhibits the reaction [Colchicine inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]] |
decreases reaction
/ increases expression |
protein |
11154858
|
D003078 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | TP53 protein affects the reaction [Colchicine results in increased phosphorylation of JUN protein] |
affects reaction
/ increases phosphorylation |
protein |
12221076
|
D003078 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | TP53 protein affects the reaction [Colchicine results in increased phosphorylation of MAPK8 protein] |
affects reaction
/ increases phosphorylation |
protein |
12221076
|
D003078 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | TP53 protein affects the reaction [Colchicine results in increased phosphorylation of MAPK9 protein] |
affects reaction
/ increases phosphorylation |
protein |
12221076
|
D003078 | 7412 |
VCAM1
CD106 INCAM-100 |
vascular cell adhesion molecule 1 | Colchicine inhibits the reaction [IL1A protein results in increased expression of VCAM1 protein] |
decreases reaction
/ increases expression |
protein |
11154858
|
D003078 | 7412 |
VCAM1
CD106 INCAM-100 |
vascular cell adhesion molecule 1 | Colchicine inhibits the reaction [TNF protein results in increased expression of VCAM1 protein] |
decreases reaction
/ increases expression |
protein |
11154858
|
D003078 | 7412 |
VCAM1
CD106 INCAM-100 |
vascular cell adhesion molecule 1 | Paclitaxel inhibits the reaction [Colchicine inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]] |
decreases reaction
/ increases expression |
mRNA |
11154858
|
D003078 | 7412 |
VCAM1
CD106 INCAM-100 |
vascular cell adhesion molecule 1 | Paclitaxel inhibits the reaction [Colchicine inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]] |
decreases reaction
/ increases expression |
protein |
11154858
|
OMIM | preferred title | UniProt |
---|---|---|
#300018 | 46,xy sex reversal 2; srxy2 |
P51843
|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#300200 | Adrenal hypoplasia, congenital; ahc |
P51843
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
O75030
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
%606641 | Body mass index; bmi |
P37231
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#114500 | Colorectal cancer; crc |
P84022
|
#614039 | Cortical dysplasia, complex, with other brain malformations 1; cdcbm1 |
Q13509
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#237500 | Dubin-johnson syndrome; djs |
Q92887
|
#128101 | Dystonia 4, torsion, autosomal dominant; dyt4 |
P04350
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600638 | Fibrosis of extraocular muscles, congenital, 3a, with or without extraocular involvement; cfeom3a |
Q13509
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 P37231 |
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237450 | Hyperbilirubinemia, rotor type; hblrr |
Q9NPD5
Q9Y6L6 |
#149400 | Hyperekplexia, hereditary 1; hkpx1 |
P23415
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#218700 | Hypothyroidism, congenital, nongoitrous, 2; chng2 |
Q06710
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#612438 | Leukodystrophy, hypomyelinating, 6; hld6 |
P04350
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#611603 | Lissencephaly 3; lis3 |
Q71U36
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#613112 | Macrothrombocytopenia, autosomal dominant, tubb1-related |
Q9H4B7
|
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#614456 | Melanoma, cutaneous malignant, susceptibility to, 8; cmm8 |
O75030
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#159900 | Myoclonic dystonia |
P14416
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
P37231 |
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#610031 | Polymicrogyria, symmetric or asymmetric; pmgysa |
Q9BVA1
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#180849 | Rubinstein-taybi syndrome 1; rsts1 |
Q92793
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#103500 | Tietz syndrome |
O75030
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#193510 | Waardenburg syndrome, type 2a; ws2a |
O75030
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | disease name | UniProt |
---|---|---|
H00038 | Malignant melanoma |
O75030
(related)
O75030 (marker) P04637 (related) |
H00169 | Ocular albinism |
O75030
(related)
|
H00759 | Waardenburg syndrome (WS) |
O75030
(related)
|
H01187 | Tietz syndrome |
O75030
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) Q06710 (related) |
H00033 | Adrenal carcinoma |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
Q06710 (related) |
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00769 | Hyperekplexia |
P23415
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
H00552 | Glycerol kinase deficiency (GKD) |
P51843
(related)
|
H00607 | 46,XY disorders of sex development (Disorders of gonadal development) |
P51843
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00838 | Congenital fibrosis of the extraocular muscles (CFEOM) |
Q13509
(related)
|
H00268 | Lissencephaly (LIS) |
Q71U36
(related)
|
H00504 | Rubinstein-Taybi syndrome |
Q92793
(related)
|
H00208 | Hyperbilirubinemia |
Q92887
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
---|---|---|---|---|---|
D015746 | D003078 | Abdominal Pain |
marker/mechanism
|
10383025
15318531 17497454 |
|
D000014 | D003078 | Abnormalities, Drug-Induced |
marker/mechanism
|
4012644
|
|
D058186 | D003078 | Acute Kidney Injury |
marker/mechanism
|
16495211
|
|
D000505 | D003078 | Alopecia |
marker/mechanism
|
405656
843157 15088997 |
|
D000544 | D003078 | Alzheimer Disease |
marker/mechanism
|
9449054
17652827 |
|
D000647 | D003078 | Amnesia |
marker/mechanism
|
2924118
|
|
D000686 | D003078 | Amyloidosis |
marker/mechanism
therapeutic |
1499522
1604496 17505274 |
|
D000740 | D003078 | Anemia |
marker/mechanism
|
6532622
|
|
D000749 | D003078 | Anemia, Megaloblastic |
marker/mechanism
|
15656036
|
|
D000783 | D003078 | Aneurysm |
marker/mechanism
|
5760170
|
|
D001002 | D003078 | Anuria |
marker/mechanism
|
17497454
|
|
D001039 | D003078 | Aphasia, Broca |
marker/mechanism
|
7725894
|
|
D001145 | D003078 | Arrhythmias, Cardiac |
marker/mechanism
|
15088997
|
|
D015210 | D003078 | Arthritis, Gouty |
therapeutic
|
3701734
5655316 14713183 17497454 20661070 |
|
D015535 | D003078 | Arthritis, Psoriatic |
therapeutic
|
17408446
|
|
D001259 | D003078 | Ataxia |
marker/mechanism
|
9460408
|
|
D001528 | D003078 | Behcet Syndrome |
therapeutic
|
2566048
6788612 9775117 9848464 11087798 12692989 15870978 |
|
D001768 | D003078 | Blister |
therapeutic
|
10028001
|
|
D001855 | D003078 | Bone Marrow Diseases |
marker/mechanism
|
405656
737005 15088997 |
|
D001927 | D003078 | Brain Diseases |
marker/mechanism
|
7403241
|
|
D001930 | D003078 | Brain Injuries |
marker/mechanism
|
2924118
|
|
D006528 | D003078 | Carcinoma, Hepatocellular |
marker/mechanism
|
8758914
11749691 |
|
D002779 | D003078 | Cholestasis |
marker/mechanism
|
3733464
15318531 |
|
D003072 | D003078 | Cognition Disorders |
marker/mechanism
|
17135773
17652827 18980205 18992766 |
|
D003218 | D003078 | Condylomata Acuminata |
therapeutic
|
843157
|
|
D003967 | D003078 | Diarrhea |
marker/mechanism
|
5538601
16240705 17497454 20131255 |
|
D004211 | D003078 | Disseminated Intravascular Coagulation |
marker/mechanism
|
4562795
|
|
D004244 | D003078 | Dizziness |
marker/mechanism
|
10383025
|
|
D004314 | D003078 | Down Syndrome |
marker/mechanism
|
4179378
4182734 |
|
D056486 | D003078 | Drug-Induced Liver Injury |
marker/mechanism
|
22331495
|
|
D062787 | D003078 | Drug Overdose |
marker/mechanism
|
17505274
|
|
D004417 | D003078 | Dyspnea |
marker/mechanism
|
14744269
|
|
D004618 | D003078 | Embolism, Air |
marker/mechanism
|
14623787
|
|
D004760 | D003078 | Enterocolitis |
marker/mechanism
|
15088997
|
|
D010505 | D003078 | Familial Mediterranean Fever |
therapeutic
|
1499522
1575022 9848464 12910572 14632592 16889161 17505274 20661070 |
|
D005221 | D003078 | Fatigue |
marker/mechanism
|
20824538
21145509 |
|
D005705 | D003078 | Gallbladder Diseases |
marker/mechanism
|
3733464
|
|
D005759 | D003078 | Gastroenteritis |
marker/mechanism
|
843157
|
|
D005767 | D003078 | Gastrointestinal Diseases |
marker/mechanism
|
10455999
17505274 |
|
D005902 | D003078 | Glaucoma, Open-Angle |
therapeutic
|
12446362
|
|
D006073 | D003078 | Gout |
therapeutic
|
1064465
2023222 2265497 2360262 3035372 5760170 6071127 7725894 9491303 9848464 11096285 11810174 11876034 12410059 15585444 16669978 17049607 19893064 |
|
D020275 | D003078 | Guillain-Barre Syndrome |
marker/mechanism
|
17097509
|
|
D006261 | D003078 | Headache |
marker/mechanism
|
10383025
|
|
D006470 | D003078 | Hemorrhage |
marker/mechanism
|
405656
|
|
D019694 | D003078 | Hepatitis B, Chronic |
therapeutic
|
9701529
|
|
D006948 | D003078 | Hyperkinesis |
marker/mechanism
|
2924118
|
|
D006955 | D003078 | Hypernatremia |
marker/mechanism
|
10383025
|
|
D006973 | D003078 | Hypertension |
marker/mechanism
|
17505274
|
|
D033461 | D003078 | Hyperuricemia |
therapeutic
|
6071127
|
|
D007010 | D003078 | Hyponatremia |
marker/mechanism
|
405656
|
|
D007039 | D003078 | Hypotrichosis |
marker/mechanism
|
17505274
|
|
D007249 | D003078 | Inflammation |
marker/mechanism
therapeutic |
9848464
15318531 |
|
D007410 | D003078 | Intestinal Diseases |
marker/mechanism
|
14623787
|
|
D007565 | D003078 | Jaundice |
marker/mechanism
|
15318531
|
|
D007674 | D003078 | Kidney Diseases |
marker/mechanism
|
3122121
|
|
D007859 | D003078 | Learning Disorders |
marker/mechanism
|
11749816
|
|
D015479 | D003078 | Leukemia, Myelomonocytic, Acute |
marker/mechanism
|
1064465
|
|
D007970 | D003078 | Leukopenia |
marker/mechanism
|
6532622
16240705 |
|
D008103 | D003078 | Liver Cirrhosis |
therapeutic
|
23146695
|
|
D008107 | D003078 | Liver Diseases |
marker/mechanism
|
2566048
10455999 17497454 |
|
D008108 | D003078 | Liver Diseases, Alcoholic |
therapeutic
|
8574231
|
|
D017114 | D003078 | Liver Failure, Acute |
marker/mechanism
|
15088997
|
|
D008569 | D003078 | Memory Disorders |
marker/mechanism
|
9449054
18992766 |
|
D009101 | D003078 | Multiple Myeloma |
marker/mechanism
|
1064465
|
|
D009102 | D003078 | Multiple Organ Failure |
marker/mechanism
|
15088997
17497454 17505274 |
|
D018908 | D003078 | Muscle Weakness |
marker/mechanism
|
5538601
7725894 8234983 9323377 10904571 11810174 12122515 14632592 14744269 15585444 16669978 17049607 17421021 19143894 20661070 |
|
D009133 | D003078 | Muscular Atrophy |
marker/mechanism
|
8234983
|
|
D009135 | D003078 | Muscular Diseases |
marker/mechanism
|
1575022
2023222 2046950 2265497 2360262 3035372 3341942 3964122 8614764 9170024 10455999 10686640 11087798 12221632 12371628 12410059 12706115 12910572 15585444 15914514 19893064 20661070 20824538 21145509 |
|
D009212 | D003078 | Myoglobinuria |
marker/mechanism
|
1499522
|
|
D009222 | D003078 | Myotonia |
marker/mechanism
|
8965841
9533795 |
|
D020967 | D003078 | Myotonic Disorders |
marker/mechanism
|
12954545
|
|
D009325 | D003078 | Nausea |
marker/mechanism
|
10383025
|
|
D009336 | D003078 | Necrosis |
marker/mechanism
|
171611
12576187 |
|
D009369 | D003078 | Neoplasms |
therapeutic
|
21472861
|
|
D009422 | D003078 | Nervous System Diseases |
marker/mechanism
|
2046950
2360262 3341942 3964122 8234983 |
|
D009436 | D003078 | Neural Tube Defects |
marker/mechanism
|
4012644
|
|
D009468 | D003078 | Neuromuscular Diseases |
marker/mechanism
|
843157
1466611 1472131 1485821 1604496 2525778 2725561 3035372 7725894 7923972 8965841 9491303 9533795 9809829 10686640 12122515 12371628 12692989 14573738 16148013 16248366 16669978 17097509 17421021 18490798 |
|
D009846 | D003078 | Oliguria |
marker/mechanism
|
16240705
17497454 |
|
D009896 | D003078 | Optic Atrophy |
marker/mechanism
|
6187703
|
|
D009901 | D003078 | Optic Nerve Diseases |
marker/mechanism
|
17421021
|
|
D010146 | D003078 | Pain |
therapeutic
|
20131255
|
|
D010195 | D003078 | Pancreatitis |
marker/mechanism
|
843157
15088997 |
|
D010198 | D003078 | Pancytopenia |
marker/mechanism
|
737005
15088997 15656036 17505274 |
|
D010243 | D003078 | Paralysis |
marker/mechanism
|
5538601
|
|
D010523 | D003078 | Peripheral Nervous System Diseases |
marker/mechanism
|
9491303
11921069 |
|
D011115 | D003078 | Polyneuropathies |
marker/mechanism
|
405656
|
|
D011141 | D003078 | Polyuria |
marker/mechanism
|
10383025
16708563 |
|
D017119 | D003078 | Porphyria Cutanea Tarda |
marker/mechanism
|
4105790
|
|
D011565 | D003078 | Psoriasis |
therapeutic
|
9848464
|
|
D011782 | D003078 | Quadriplegia |
marker/mechanism
|
16148013
|
|
D012021 | D003078 | Reflex, Abnormal |
marker/mechanism
|
8234983
|
|
D051437 | D003078 | Renal Insufficiency |
marker/mechanism
|
405656
1499522 10455999 16240705 17497454 |
|
D012131 | D003078 | Respiratory Insufficiency |
marker/mechanism
|
843157
|
|
D012206 | D003078 | Rhabdomyolysis |
marker/mechanism
|
14713183
15389652 17497454 |
|
D012640 | D003078 | Seizures |
marker/mechanism
|
6509321
6884477 |
|
D018805 | D003078 | Sepsis |
marker/mechanism
|
405656
17505274 |
|
D012790 | D003078 | Shwartzman Phenomenon |
marker/mechanism
|
4562795
|
|
D012871 | D003078 | Skin Diseases |
therapeutic
|
2566048
|
|
D013281 | D003078 | Stomatitis, Aphthous |
therapeutic
|
2566048
|
|
D020955 | D003078 | Striatonigral Degeneration |
marker/mechanism
|
18564367
|
|
D016463 | D003078 | Sweet Syndrome |
therapeutic
|
9848464
|
|
D013616 | D003078 | Tachycardia, Sinus |
marker/mechanism
|
17497454
|
|
D013921 | D003078 | Thrombocytopenia |
marker/mechanism
|
6532622
16240705 17497454 |
|
C536522 | D003078 | Vacuolar myopathy |
marker/mechanism
|
8234983
9394328 11810174 12399640 12954545 16669978 |
|
D014786 | D003078 | Vision Disorders |
marker/mechanism
|
17421021
|
|
D014806 | D003078 | Vitamin B 12 Deficiency |
marker/mechanism
|
15656036
|
|
D014839 | D003078 | Vomiting |
marker/mechanism
|
10383025
16240705 20131255 |
|
D015431 | D003078 | Weight Loss |
marker/mechanism
|
405656
|